Early research (Phase 1)UnknownNCT05235438
What this trial is testing
Safety and Toxicity Study of IMM27M in Patients With Advanced Solid Tumor
Who this might be right for
OncologyCTLA4 Haploinsufficiency
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 16